Curaleaf Addresses Aurora Cannabis' Latest Maneuvers to Distract from Shareholder Value

Curaleaf Holdings, Inc. has recently reacted to the latest public statements made by Aurora Cannabis Inc. regarding their discussions on a potential deal. According to Curaleaf, Aurora’s selective statistics and misleading characterizations have failed to give a clear picture of the realities surrounding shareholder value. In an effort to clarify their stance, Curaleaf has reiterated its openness to engage in meaningful discussions that prioritize shareholder interests.

Curaleaf’s Stance on Aurora's Claims

Curaleaf strongly maintains that Aurora’s claims are mere distractions. The company noted that if Aurora was genuinely delivering on its multi-year turnaround strategy, the market would have appropriately reflected that through its valuation—something that has not occurred. Curaleaf argues that their offer not only provides shareholders with a substantial premium but also suggests an exciting opportunity for them to be part of a larger, more robust global cannabis platform.

Furthermore, Curaleaf's management team has established a proven history of increasing shareholder value, and it is eager to extend that track record to Aurora's shareholders.

Mischaracterization of Engagement by Aurora

Curaleaf expressed disappointment over Aurora's interpretation of their discussions, labeling it as an insult to shareholders. The company asserted that there has been no substantial conversation about a deal; rather, they feel Aurora has been evasive. Curaleaf has made all correspondence regarding the matter publicly available on their website for transparency.

The statements circulating from Curaleaf highlight Aurora’s inability to engage constructively. Despite making insightful claims about openness, Aurora has refrained from signing non-disclosure agreements or allowing for any substantive discussions, which is seen as contrary to genuine engagement practices. Curaleaf has indicated its willingness to meet at any time to further discuss potential arrangements.

Highlighting Aurora's Underperformance

In its defense, Curaleaf pointed out the broader performance trends under Aurora’s management. The company highlighted that over the past few years, Aurora stocks have declined by approximately 35%, while Curaleaf's shares have significantly increased by about 56%. Curaleaf has pointed out the substantial losses that have plagued Aurora, which include over C$400 million in inventory impairments and ongoing transformation costs.

Curaleaf also expressed skepticism toward claims of international growth touted by Aurora. They argue that while Aurora has indicated a 17% growth rate, it has conveniently overlooked recent declines in their operations that have led to a significant drop in revenue.

The Favorable Market Response to Curaleaf's Offer

In the wake of Curaleaf's proposal, the company's share price has shown significant movement, trading closely around the implied value of Curaleaf's offer. This response from the market underscores a recognition of the strategic logic and potential value of the transaction, even as Aurora’s management appears dismissive of the proposal.

The prevailing sentiment in the market suggests that investors are keenly aware of the advantages that Curaleaf's offer presents. Thus, Curaleaf urges Aurora shareholders to thoroughly read the offer and accompanying documents available on their website, illuminating the strategic rationale behind the acquisition proposal.

A Future Built on Collaboration

Curaleaf, known for its commitment to quality and its strong market presence throughout various geographical regions, remains dedicated to empowering shareholders and enhancing overall value in the cannabis space. The company’s continuing narrative revolves around cultivating and sharing the power of cannabis, a mission that resonates with many in today’s evolving market.

In conclusion, Curaleaf is eager to navigate this transitional phase with Aurora in a productive manner that serves the best interests of all shareholders involved. The offer stands as a testament to Curaleaf's commitment to an enduring relationship built on shared success, as they invite further open and constructive discussions moving forward.

For more information, visit Curaleaf's investor relations page where comprehensive details regarding their proposal and associated benefits can be found.